Investigating the transurothelial delivery of therapeutic agents

Intravesical drug delivery (IDD) offers a unique opportunity to target pathology of the lower urinary tract. High concentrations of drug can be delivered directly to the bladder with minimal systemic absorption. IDD has been used successfully to manage a range of conditions such as bladder cancer an...

Full description

Bibliographic Details
Main Author: Williams, Nicholas
Published: Cardiff University 2015
Subjects:
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.655950
id ndltd-bl.uk-oai-ethos.bl.uk-655950
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6559502018-10-09T03:25:03ZInvestigating the transurothelial delivery of therapeutic agentsWilliams, Nicholas2015Intravesical drug delivery (IDD) offers a unique opportunity to target pathology of the lower urinary tract. High concentrations of drug can be delivered directly to the bladder with minimal systemic absorption. IDD has been used successfully to manage a range of conditions such as bladder cancer and overactive bladder and continues to be investigated for novel indications. Despite this the majority of IDD regimens remain empirically driven and as a result its potential largely unfulfilled. This thesis developed and validated an ex' vivo porcine model to investigate the transurothelial delivery and bladder wall distribution of drugs after topical application to the urothelium. Using the model, transurothelial permeability coefficients were determined and tissue layer specific bladder wall concentrations calculated for a range of clinically relevant drugs including ketorolac and oxybutynin. The results of these studies were used to inform on the viability of delivering these drugs intravesically in' vivo. Additionally a computer - based pharmacokinetic model of IDD was developed using STELLA® modelling software. The model was used to investigate the key variables associated with IDD and suggest novel techniques and dosing concepts to improve its efficacy. For the first time, the relative permeability of the upper and lower urinary tract was investigated for a single drug. Ex'vivo porcine ureteral urothelium was shown to be significantly more permeable to mitomycin C than that of the bladder. If translated into human, the more permeable urothelium may provide higher target tissue concentrations after local delivery and a significant opportunity to manage upper tract urothelial carcinoma conservatively. This project developed novel ex'vivo and in'silico methods to investigate IDD. These techniques can be used to rationally inform on the design of new, or optimisation of existing, IDD regimens.Q Science (General)Cardiff Universityhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.655950http://orca.cf.ac.uk/74444/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic Q Science (General)
spellingShingle Q Science (General)
Williams, Nicholas
Investigating the transurothelial delivery of therapeutic agents
description Intravesical drug delivery (IDD) offers a unique opportunity to target pathology of the lower urinary tract. High concentrations of drug can be delivered directly to the bladder with minimal systemic absorption. IDD has been used successfully to manage a range of conditions such as bladder cancer and overactive bladder and continues to be investigated for novel indications. Despite this the majority of IDD regimens remain empirically driven and as a result its potential largely unfulfilled. This thesis developed and validated an ex' vivo porcine model to investigate the transurothelial delivery and bladder wall distribution of drugs after topical application to the urothelium. Using the model, transurothelial permeability coefficients were determined and tissue layer specific bladder wall concentrations calculated for a range of clinically relevant drugs including ketorolac and oxybutynin. The results of these studies were used to inform on the viability of delivering these drugs intravesically in' vivo. Additionally a computer - based pharmacokinetic model of IDD was developed using STELLA® modelling software. The model was used to investigate the key variables associated with IDD and suggest novel techniques and dosing concepts to improve its efficacy. For the first time, the relative permeability of the upper and lower urinary tract was investigated for a single drug. Ex'vivo porcine ureteral urothelium was shown to be significantly more permeable to mitomycin C than that of the bladder. If translated into human, the more permeable urothelium may provide higher target tissue concentrations after local delivery and a significant opportunity to manage upper tract urothelial carcinoma conservatively. This project developed novel ex'vivo and in'silico methods to investigate IDD. These techniques can be used to rationally inform on the design of new, or optimisation of existing, IDD regimens.
author Williams, Nicholas
author_facet Williams, Nicholas
author_sort Williams, Nicholas
title Investigating the transurothelial delivery of therapeutic agents
title_short Investigating the transurothelial delivery of therapeutic agents
title_full Investigating the transurothelial delivery of therapeutic agents
title_fullStr Investigating the transurothelial delivery of therapeutic agents
title_full_unstemmed Investigating the transurothelial delivery of therapeutic agents
title_sort investigating the transurothelial delivery of therapeutic agents
publisher Cardiff University
publishDate 2015
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.655950
work_keys_str_mv AT williamsnicholas investigatingthetransurothelialdeliveryoftherapeuticagents
_version_ 1718772213389197312